Acer Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Acer Therapeutics

19/11/2021 23:15

* Acer Therapeutics Inc  ACER.OQ  reported a quarterly adjusted
loss of 23 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 28 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Acer Therapeutics Inc's reported EPS for the quarter was a
loss of 23 cents​.
* The mean earnings estimate of analysts had risen by about 2.6%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Acer Therapeutics Inc shares had fallen by 9.4% this
quarter and lost 11.5% so far this year.
* The company reported a quarterly loss of $3.27 million.
* Wall Street's median 12-month price target for Acer
Therapeutics Inc is $10.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 19 at 11:15 p.m.
 ​All figures in US dollars unless otherwise stated